Massively parallel sequencing of ataxia genes after array-based enrichment
- PMID: 20151403
- DOI: 10.1002/humu.21221
Massively parallel sequencing of ataxia genes after array-based enrichment
Abstract
Massively parallel sequencing has tremendous diagnostic potential but requires enriched templates for sequencing. Here we report the validation of an array-based sequence capture method in genetically heterogeneous disorders. The model disorder selected was AR ataxia, using five subjects with known mutations and two unaffected controls. The genomic sequences of seven disease genes, together with two control loci were targeted on a 2-Mb sequence-capture array. After enrichment, the patients' DNA samples were analyzed using one-quarter Roche GS FLX Titanium sequencing run, resulting in an average of 65 Mb of sequence data per patient. This was sufficient for an average 25-fold coverage/base in all targeted regions. Enrichment showed high specificity; on average, 80% of uniquely mapped reads were on target. Importantly, this approach enabled automated detection of deletions and hetero- and homozygous point mutations for 6/7 mutant alleles, and greater than 99% accuracy for known SNP variants. Our results also clearly show reduced coverage for sequences in repeat-rich regions, which significantly impacts the reliable detection of genomic variants. Based on these findings we recommend a minimal coverage of 15-fold for diagnostic implementation of this technology. We conclude that massive parallel sequencing of enriched samples enables personalized diagnosis of heterogeneous genetic disorders and qualifies for rapid diagnostic implementation.
(c) 2010 Wiley-Liss, Inc.
Similar articles
-
Targeted high throughput sequencing of a cancer-related exome subset by specific sequence capture with a fully automated microarray platform.Genomics. 2010 Apr;95(4):241-6. doi: 10.1016/j.ygeno.2010.01.006. Epub 2010 Feb 6. Genomics. 2010. PMID: 20138981
-
Array-based sequence capture and next-generation sequencing for the identification of primary immunodeficiencies.Scand J Immunol. 2012 Mar;75(3):350-4. doi: 10.1111/j.1365-3083.2011.02658.x. Scand J Immunol. 2012. PMID: 22017423
-
Repeat subtraction-mediated sequence capture from a complex genome.Plant J. 2010 Jun 1;62(5):898-909. doi: 10.1111/j.1365-313X.2010.04196.x. Epub 2010 Mar 4. Plant J. 2010. PMID: 20230488
-
Impacts of massively parallel sequencing for genetic diagnosis of neuromuscular disorders.Acta Neuropathol. 2013 Feb;125(2):173-85. doi: 10.1007/s00401-012-1072-7. Epub 2012 Dec 7. Acta Neuropathol. 2013. PMID: 23224362 Review.
-
Enzymatic mutation detection technologies.Biotechniques. 2005 May;38(5):749-58. doi: 10.2144/05385RV01. Biotechniques. 2005. PMID: 15948293 Review.
Cited by
-
Exome sequencing: the sweet spot before whole genomes.Hum Mol Genet. 2010 Oct 15;19(R2):R145-51. doi: 10.1093/hmg/ddq333. Epub 2010 Aug 12. Hum Mol Genet. 2010. PMID: 20705737 Free PMC article. Review.
-
Novel loss-of-function mutation in BRCA2 gene identified in a Chinese female with a family history of ovarian cancer: A case report.Oncol Lett. 2019 Mar;17(3):3350-3354. doi: 10.3892/ol.2019.9950. Epub 2019 Jan 21. Oncol Lett. 2019. PMID: 30867769 Free PMC article.
-
Accurate and exact CNV identification from targeted high-throughput sequence data.BMC Genomics. 2011 Apr 12;12:184. doi: 10.1186/1471-2164-12-184. BMC Genomics. 2011. PMID: 21486468 Free PMC article.
-
Target capture and massive sequencing of genes transcribed in Mytilus galloprovincialis.Biomed Res Int. 2014;2014:538549. doi: 10.1155/2014/538549. Epub 2014 Jun 30. Biomed Res Int. 2014. PMID: 25101286 Free PMC article.
-
Development of a high-throughput resequencing array for the detection of pathogenic mutations in osteogenesis imperfecta.PLoS One. 2015 Mar 5;10(3):e0119553. doi: 10.1371/journal.pone.0119553. eCollection 2015. PLoS One. 2015. PMID: 25742658 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous